Vitamin D in type 1 diabetes prevention

Area of Science:

• Pediatric Endocrinology
• Nutritional Immunology
• Public Health Nutrition

Background:

• Limited human data exist on vitamin D supplementation and type 1 diabetes risk.
• Observational studies suggest low-dose vitamin D (<10 mcg/day) may not be protective, while higher doses (≥50 mcg/day) might offer protection.
• Current US recommendations (5-25 mcg/day) fall within an understudied dosage range.

Purpose of the Study:

• To evaluate the association between vitamin D levels and type 1 diabetes-predictive autoantibodies.
• To determine the efficacy of vitamin D supplementation in preventing autoantibodies and type 1 diabetes.
• To assess the safety of higher vitamin D intake levels in children.

Main Methods:

• Investigate the relationship between 25-hydroxyvitamin D and type 1 diabetes autoantibodies.
• Conduct trials on vitamin D doses ranging from 5 to 50 mcg/day for prevention.
• Examine the safety profile of vitamin D intakes at 25 mcg/day and above.

Main Results:

• Lower doses of vitamin D (≤10 mcg/day) showed no significant risk reduction for type 1 diabetes.
• Higher doses (≥50 mcg/day) indicated a potential strong protective effect against type 1 diabetes.
• The 5-25 mcg/day range, currently recommended in the US, remains largely unstudied for efficacy.

Conclusions:

• All infants and children should receive 5-25 mcg/day of supplemental vitamin D, with higher doses considered for those at increased risk.
• Further research is crucial to establish optimal vitamin D dosing for type 1 diabetes prevention and to evaluate safety.
• Vitamin D's role in type 1 diabetes prevention should be considered in screening decisions and future guideline revisions.